Deliang Fu

3.9k total citations · 1 hit paper
99 papers, 2.7k citations indexed

About

Deliang Fu is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Deliang Fu has authored 99 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 35 papers in Molecular Biology and 29 papers in Surgery. Recurrent topics in Deliang Fu's work include Pancreatic and Hepatic Oncology Research (63 papers), Pancreatitis Pathology and Treatment (18 papers) and Epigenetics and DNA Methylation (11 papers). Deliang Fu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (63 papers), Pancreatitis Pathology and Treatment (18 papers) and Epigenetics and DNA Methylation (11 papers). Deliang Fu collaborates with scholars based in China, United States and Canada. Deliang Fu's co-authors include Chen Jin, Feng Yang, Di Yang, Quanxing Ni, Yongjian Jiang, Ji Li, Jin Chen, Yishen Mao, Zhibo Xie and Jin Xu and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Deliang Fu

94 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives

2021 220 citations Deliang Fu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deliang Fu China	28	1.3k	994	621	482	471	99	2.7k
Michael H. Muders Germany	30	904 0.7×	1.3k 1.3×	502 0.8×	395 0.8×	370 0.8×	79	2.7k
Qichun Wei China	30	903 0.7×	1.2k 1.2×	487 0.8×	523 1.1×	304 0.6×	138	3.2k
James O. Park United States	28	722 0.5×	909 0.9×	270 0.4×	617 1.3×	399 0.8×	92	2.6k
Vuong Trieu United States	23	2.0k 1.5×	1.2k 1.2×	889 1.4×	565 1.2×	607 1.3×	92	4.1k
Jihui Hao China	32	1.2k 0.9×	1.4k 1.4×	792 1.3×	434 0.9×	200 0.4×	117	3.1k
Jianbo Wang China	29	800 0.6×	1.2k 1.2×	768 1.2×	401 0.8×	455 1.0×	125	2.9k
Hao Xiong United States	29	1.6k 1.2×	2.0k 2.0×	377 0.6×	300 0.6×	325 0.7×	132	4.4k
Shuzhong Cui China	25	668 0.5×	1.4k 1.4×	884 1.4×	699 1.5×	324 0.7×	91	2.9k
Shamit K. Dutta United States	31	723 0.5×	1.6k 1.6×	565 0.9×	350 0.7×	196 0.4×	62	2.6k
Seong‐Yun Jeong South Korea	26	759 0.6×	1.1k 1.2×	357 0.6×	677 1.4×	164 0.3×	84	2.5k

Countries citing papers authored by Deliang Fu

Since Specialization

Citations

This map shows the geographic impact of Deliang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deliang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deliang Fu more than expected).

Fields of papers citing papers by Deliang Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deliang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deliang Fu. The network helps show where Deliang Fu may publish in the future.

Co-authorship network of co-authors of Deliang Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Deliang Fu. A scholar is included among the top collaborators of Deliang Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deliang Fu. Deliang Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Xi, Caifeng Zou, Yishen Mao, et al.. (2024). Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth. Journal of Translational Medicine. 22(1). 1135–1135. 9 indexed citations

Zhou, Siyu, Yujie Guo, Heng-Chao Li, et al.. (2024). Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer. Journal of Translational Medicine. 22(1). 557–557. 5 indexed citations

Guo, Yujie, et al.. (2022). The expression and survival significance of sodium glucose transporters in pancreatic cancer. BMC Cancer. 22(1). 116–116. 13 indexed citations

Yuan, Meng, Bo Tu, Huanhuan Pang, et al.. (2022). Cancer-associated fibroblasts employ NUFIP1-dependent autophagy to secrete nucleosides and support pancreatic tumor growth. Nature Cancer. 3(8). 945–960. 63 indexed citations

Wang, Yu, Yiyi Liang, Haiyan Xu, et al.. (2021). Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discovery. 7(1). 36–36. 172 indexed citations

Xie, Zhibo, Ya Gao, Chiakang Ho, et al.. (2021). Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut. 71(3). 568–579. 139 indexed citations

Wang, Xue, Wei Li, Tao Zhang, et al.. (2019). Anti-PD1 up-regulates PD-L1 expression and inhibits T-cell lymphoma progression: possible involvement of an IFN-γ-associated JAK-STAT pathway. SHILAP Revista de lepidopterología. 2 indexed citations

Xie, Zhibo, Yifan Zhang, Chen Jin, Yishen Mao, & Deliang Fu. (2019). LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling. Journal of Experimental & Clinical Cancer Research. 38(1). 75–75. 47 indexed citations

Zhang, Shirong, Lie Yao, Wenquan Wang, et al.. (2018). Tumor-Infiltrating Platelets Predict Postsurgical Survival in Patients with Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology. 25(13). 3984–3993. 23 indexed citations

10.

Li, You, Feng Yang, & Deliang Fu. (2018). Prediction of malignancy and adverse outcome of solid pseudopapillary tumor of the pancreas. World Journal of Gastrointestinal Oncology. 10(7). 184–193. 27 indexed citations

11.

Zhou, Guofeng, Xiaoyu Liu, Xiaoyi Wang, et al.. (2017). Combination of preoperative CEA and CA19-9 improves prediction outcomes in patients with resectable pancreatic adenocarcinoma: results from a large follow-up cohort. OncoTargets and Therapy. Volume 10. 1199–1206. 21 indexed citations

12.

Yao, Lie, Zhibo Xie, Jin Chen, et al.. (2017). Radical resection and enucleation in Chinese adolescents with pancreatic tumors. Medicine. 96(12). e6438–e6438. 2 indexed citations

13.

Fu, Deliang. (2016). Determination of amino acids in mannatide by online pre-column OPA-FMOC derivatization HPLC. Chinese Journal of Analysis Laboratory. 2 indexed citations

14.

He, Hang, Sijie Hao, Lie Yao, et al.. (2014). MicroRNA-218 inhibits cell invasion and migration of pancreatic cancer via regulating ROBO1. Cancer Biology & Therapy. 15(10). 1333–1339. 35 indexed citations

15.

He, Hang, Yongjian Jiang, Di Yang, et al.. (2013). Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis. Medical Oncology. 30(4). 700–700. 50 indexed citations

16.

Yang, Feng, Jin Chen, Qiang Wang, et al.. (2012). Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment. Cancer Treatment Reviews. 38(6). 566–579. 101 indexed citations

17.

Luo, Guopei, Xianjun Yu, Chen Jin, et al.. (2009). LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumors. International Journal of Pharmaceutics. 385(1-2). 150–156. 123 indexed citations

18.

Xu, Jin, Jin Chen, Sijie Hao, Guopei Luo, & Deliang Fu. (2009). Pancreatic cancer: gene therapy approaches and gene delivery systems. Expert Opinion on Biological Therapy. 10(1). 73–88. 8 indexed citations

19.

Yang, Feng, Deliang Fu, Chen Jin, et al.. (2008). Clinical experiences of solid pseudopapillary tumors of the pancreas in China. Journal of Gastroenterology and Hepatology. 23(12). 1847–1851. 40 indexed citations

20.

Fu, Deliang. (2000). Three decades′ development of radical surgery for cancer at the head of pancreas: a report of 377 cases. Zhonghua gan-dan waike zazhi.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact